Agenus | AGEN - Trade Creditors


Agenus reported $82.99M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agenus USD 82.99M 2.3M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Celldex Therapeutics USD 1.18M 3.09M Dec/2025
CSL USD 3.17B 290M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Glaxosmithkline GBP 20.72B 346.14M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
J&J USD 11.99B 2.37B Dec/2025
Jiangsu Hengrui CNY 2.27B 45.68M Dec/2025
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
MacroGenics USD 4.79M 1.15M Dec/2025
Merck EUR 2.11B 182M Dec/2025
Merck USD 4.15B 102M Sep/2025
Northwest Biotherapeutics 27.22M 5.8M Mar/2025
Novartis USD 4.46B 99M Dec/2025
Novavax USD 24.58M 9.35M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Veracyte USD 4.59M 916K Dec/2025